The vaping cessation pill, varenicline, has emerged as a groundbreaking solution for those struggling to quit vaping, particularly among teens and young adults.Recent clinical trials reveal that individuals aged 16 to 25 using this FDA-approved medication are over three times more successful in overcoming their nicotine addiction compared to those only undergoing behavioral counseling.